Olanzapine for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a randomized controlled trial

CONCLUSION: Our data suggest that olanzapine relative to placebo decreased the risk of nausea and/or vomiting in the 24 h after gynecologic laparoscopic surgery.TRIAL REGISTRATION: The trial was registered prior to patient enrollment at The Chinese Clinical Trial Registry (https://www.chictr.org.cn/showproj.html?proj=166900, link to registry page, Principal investigator: Nanjin Chen, Date of registration: 25 April 2022).PMID:38646425 | PMC:PMC11027591 | DOI:10.1177/20420986241244593

Source: Adv Data - April 22, 2024 Category: Epidemiology Authors: Nanjin Chen Shuman Ji Junfei Liu Liping Wang Fenglin Chen Yanwu Zhu Jiao Li Minjuan Chen Lingyang Chen Mingcang Wang Ruyi He Xiaopeng Mei Zhanqin Zhang Shengwei Jin Jingming Zheng Yongpo Jiang Source Type: research